Business Context and Reporting Period
This Form 8-K Current Report was filed by Rocket Pharmaceuticals, Inc. (RCKT) on April 7, 2025. The filing reports the appointment of a new senior executive officer and the terms of the associated employment agreement.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation and appointment details.
Material Changes
The primary material change reported is the appointment of Sarbani Chaudhuri as Chief Commercial & Medical Affairs Officer, effective April 7, 2025. This represents a significant addition to the company's leadership team, bringing extensive experience from Johnson & Johnson, AstraZeneca, Pfizer, and Novartis.
Management Commentary and Compensation Details
The filing details the Executive Employment Agreement entered into with Ms. Chaudhuri:
- Base Salary: $525,000 annually.
- Target Bonus: 45% of the annual base salary.
- Equity Grant: Approximately $2,500,000 in total value, split equally between stock options and restricted stock units (RSUs). Vesting occurs with one-third on the first anniversary and the remaining two-thirds over eight quarterly increments.
- Sign-on Bonus: $100,000, payable 30 days after the start date contingent on continued employment.
- Severance: Nine months of base salary and COBRA benefits upon qualifying termination. In the event of a qualifying termination within 12 months of a Change in Control, the package increases to 12 months of base salary, the full annual bonus, and 12 months of COBRA benefits.
Investor Verification Checklist
- Verify the full text of the Executive Employment Agreement when filed as an exhibit to the Form 10-Q for the quarter ended March 31, 2025.
- Confirm the impact of the new equity grant ($2.5M) on the company's existing share count and dilution.
- Monitor the company's commercial strategy updates following the appointment of the new Chief Commercial & Medical Affairs Officer.